Inhalation Sciences’ new CEO in revealing first broadcast interview
Posted 28 juni 2018 in Okategoriserade
”We’ve built up our pipeline of leads from 20 or 30 – to 80, of those I think we have 8 really hot leads”. Meet new ISAB CEO…
Read morePosted 28 juni 2018 in Okategoriserade
”We’ve built up our pipeline of leads from 20 or 30 – to 80, of those I think we have 8 really hot leads”. Meet new ISAB CEO…
Read morePosted 28 juni 2018 in Okategoriserade
”We’ve built up our pipeline of leads from 20 or 30 – to 80, of those I think we have 8 really hot leads”. Meet new ISAB CEO…
Read morePosted 31 maj 2018 in Okategoriserade
EU authorities have approved and released a final payment of 2 MSEK to ISAB for its four-year work on the FORMAMP project. The project has been profitable scientifically…
Read morePosted 08 maj 2018 in Okategoriserade
In her last CEO role Lena Heffler tripled the number of customers for a blood cancer analysis tool—in just 24 months. Her insight? Reaching out to a new,…
Read morePosted 09 april 2018 in Okategoriserade
Den 15:e mars lämnade Inhalation Sciences en uppdatering av planerna för notering av Ziccum AB. Till följd av de frågor som ställdes i samband med bolagets presentation på…
Read morePosted 23 februari 2018 in Okategoriserade
Inhalation Sciences bjuder in ägare och investerare till en lunchträff med syftet att ge en uppdatering om Inhalation Sciences samt för första gången presentera Ziccum AB i egen regi. Lunchträffen…
Read morePosted 23 februari 2018 in Okategoriserade
Inhalation Sciences technology was instrumental to the research of five scientific posters at SOT, San Antonio, US, March 11-15, including three abstracts from Karolinska Institutet (KI) Institute of…
Read morePosted 23 februari 2018 in Okategoriserade
Inhalation Sciences (ISAB) has recruited a new Product Engineer as part of ongoing commercialization. KTH Royal Institute of Technology graduate Joel Mared joins the lab team in Stockholm….
Read morePosted 20 februari 2018 in Okategoriserade
Approx. 450 human antibodies are currently being developed to treat a wide range of diseases—but many are formulated as liquids, risking instability and attrition in clinical trials. Ziccum…
Read morePosted 14 februari 2018 in Okategoriserade
Inhalation Sciences technology was instrumental to the research of five scientific posters at SOT, San Antonio, US, March 11-15, including three abstracts from Karolinska Institutet (KI) Institute of…
Read more